A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This Is A Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib
(Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic
Arthritis
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.